We were heartened this year by World Diabetes Day, which officially recognizes the growing epidemics of diabetes, diabetes complications, and obesity. Every year on...

(S)he said what?!?

Last week, in a surprise and, in our view, disappointing move, the FDA decided to not approve Bydureon, a once-weekly GLP-1 agonist, for use in the United States despite...

Even though exercise and weight loss have been shown to reduce a person’s chance of developing type 2 diabetes, healthcare providers have not traditionally reimbursed...

Stellar diabetes experts descend on San Francisco for the ADA’s 57th Annual Advanced Postgraduate Course.

Teaching a child with type 1 diabetes the "facts of life"... Jim Hirsch reflects.

The LAP-BAND is a weight-loss device that is implanted around the top of the stomach using minimally invasive (laparoscopic) surgery, which effectively creates a small...

No doubt, you have in all likelihood heard about the FDA’s decision to restrict access to Avandia, based on data suggesting its use is associated with an elevated risk...

An evolutionary step for Paradigm pumpers – see Dana Lewis’s take on Medtronic’s new pump/CGM integrated platform the Paradigm REAL-Time Revel system.

While we’re willing to bet that most people with diabetes think that blood glucose meters are an important tool, there is surprisingly little scientific evidence...

Abbott received CE Mark approval for FreeStyle InsuLinx blood glucose meter. Since receiving CE Mark approval for its FreeStyle InsuLinx in Europe, Abbott has launched...

Do insulin pumps always pump the same? Read on to learn more about the “siphon effect.”

The FDA just approved Medtronic’s latest insulin pump, called the MiniMed Paradigm REAL-Time Revel System – this is Medtronic’s first new pump platform to be approved in...

A thorough review and “how-to” on the drug Symlin (Amylin’s pramlintide).

Kelly highlights an important diaTribe milestone and debriefs readers on the latest developments in diabetes technology.

Earlier this week, the FDA chose not to approve the weight-loss drug Qnexa. Qnexa is a combination of two currently approved drugs: phentermine, which is approved for...

AADE spotlights self-management and patient-provider interactions.

CVS recently announced the introduction of new monitoring services for people with diabetes offered through its MinuteClinic walk-in healthcare clinics. Dubbed...

A girl can dream, right? (...of cures and new insulins...)

Kelly here, the founder of diaTribe . Are you a woman interested in connecting with other women with diabetes and learning more about the unique challenges of diabetes?...